Joanna Zurko, MD, Medical College of Wisconsin, Milwaukee, WI, explains the importance of identifying copper deficiency early to distinguish it from myelodysplastic syndromes (MDS), discussing a patient case study. This will allow preventing permanent neurological deficits and poor response to allogeneic hematopoietic stem cell transplantation (alloHSCT). This interview took place at the Transplantation & Cellular Therapy (TCT) Meetings of ASTCT™ and CIBMTR® 2022 in Salt Lake City, Utah.